28
Jun
2021
12:00
BST
13:00
CEST
Webinar
Optimal Antiplatelet Therapy In NSTE-ACS: Results From A Novel Crowdsourcing Survey
-
Views:
3882
-
Likes:
13
Overview
The choice and duration of antiplatelet therapy in NSTE-ACS undergoing PCI is complex and is a hotly debated topic – particularly amongst patients at high bleeding risk. To gain insight into the real-world practices of a global cross-section of cardiologists, Radcliffe Medical Education, in partnership with the International Society of Cardiovascular Pharmacotherapy (ISCP), undertook a novel crowdsourcing project to capture their prevailing beliefs and practices in antiplatelet treatment, in patients at high bleeding risk.
We reported our findings in a paper recently published in the International Journal of Cardiology and are delighted to now bring you a roundtable discussion, featuring members of the steering committee, to further explain the project, the main findings, and the potential implications for future research.
To view the article please click here
To view the questions asked in the survey please click to 'download slides'.
This project was made possible by an unrestricted educational grant from AstraZeneca.
Faculty:
Juan Carlos Kaski
Deepak L Bhatt
Felicita Andreotti
Dominick J Angiolillo
This webinar is supported by
Agenda
Key Learning Objectives
- Describe current guideline-led recommendations for the use and duration of dual antiplatelet therapy in NSTE-ACS patients at high bleeding risk
- Explain how alternative antiplatelet strategies differ to those advocated in current international guidelines for high bleeding risk individuals
- Recall how practice varied in prescribers who took part in the crowdsourcing project
- Describe how a crowdsourcing methodology may have potential implications for future research
Research Data Gathered From
- 559 respondents
- 70 countries
- Specialisms included interventional cardiologists, non-invasive cardiologists and other prescribers
- Physician representation from state and public hospitals, private hospitals, university and teaching hospitals plus research institutes
Faculty Biographies
Juan Carlos Kaski
Juan Carlos Kaski is Professor of Cardiovascular Science (Emeritus) at the Molecular and Clinical Sciences Research Institute, St Gorge’s, University of London, and Hon. Consultant Cardiologist at St George’s Hospital and the Royal Brompton Hospital in London, UK.
Deepak L Bhatt
Dr Deepak Bhatt is Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School.
Felicita Andreotti
Prof Felicita Andreotti is a tenured Professor and Medical Director at the Gemelli IRCCS Hospital and Catholic University in Rome, Italy, where she currently coordinates cardiovascular research within the Scientific Directorate.
Dominick J Angiolillo
Dr Dominick Angiolillo graduated from the Catholic University of the Sacred Heart Medical School in Rome, Italy and pursued training in interventional cardiology at the Complutense University of Madrid in Spain and received his Ph.D.